Last reviewed · How we verify
NCT03769701
Efficacy of Two Schemes of Self-monitoring Capillary Glucose in Gestational Diabetes
NA trial testing self-monitoring capillary glucose (SMCG) in Gestational Diabetes in 110 participants. Status unknown.
30 April 2022
Quick facts
| Lead sponsor | Instituto Nacional de Perinatologia Isidro Espinosa de los Reyes |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | other |
| Enrollment | 110 |
| Start date | 7 December 2018 |
| Primary completion | 30 April 2022 |
| Estimated completion | 30 July 2022 |
| Sites | 1 location across Mexico |
Drugs / interventions tested
- self-monitoring capillary glucose (SMCG)
Conditions studied
- Gestational Diabetes — all drugs for Gestational Diabetes →
Sponsor
Instituto Nacional de Perinatologia Isidro Espinosa de los Reyes — full company profile →
Who can join
Adults 18 to 45, female only, with Gestational Diabetes. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Gestational diabetes mellitus (GDM) affects 10 % of women who receive prenatal care at Instituto Nacional de Perinatología (Mexico, City). Currently, there is clear evidence on the utility of self- monitoring of capillary glucose (SMGC) to evaluate the efficacy of medical-nutrition therapy on glycemic control. However, the reports regarding the best pattern of SMGC in terms of frequency and number of determinations per day are limited. The objective of this study is to evaluate the efficacy of two SMGC schemes for monitoring glycemic control in Mexican women with GDM.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03769701
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Gestational Diabetes
Currently open trials in the same condition.
- NCT07171684 — Single vs Multi-Dose Insulin for Glycemic Control (SUGAR) · NA · recruiting
- NCT07314944 — Maternal Sleep and Lifestyle, Metabolic Health, and Perinatal Outcomes in Gestational Diabetes · recruiting
- NCT06571487 — Growth Hormone Resistance of Beta-cells · recruiting
- NCT07336914 — Effect of Conventional vs Intensive Management on Gestational Diabetes and Maternal Fetal Outcomes · NA · recruiting
- NCT07174245 — Pregnancy and Postpartum CGM in GDM · recruiting
Other Instituto Nacional de Perinatologia Isidro Espinosa de los Reyes trials
Trials by the same sponsor.
- NCT06195176 — Randomized Clinical Trial: Effect of an Exercise Routine on Postoperative Shoulder Pain in Laparoscopic Hysterectomy · NA · recruiting
- NCT05158673 — Effect of Cocoa Polyphenols Supplementation on Cardiovascular Risk of Postmenopausal Women · NA · unknown
- NCT03578341 — Oral Colostrum and Its Effect on Immune System · Phase 3 · unknown
- NCT03090997 — Effect of Resveratrol and Vitamin C on Insulin Resistance Among Postmenopausal Women · NA · unknown
- NCT03274596 — Effect of Vitamin E for Prevention of Retinopathy of Prematurity: A Randomized Clinical Trial. · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03769701 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Instituto Nacional de Perinatologia Isidro Espinosa de los Reyes
- Last refreshed: 28 December 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03769701.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing